INDRENEW stock news
This page provides real-time market news, earnings updates, and company announcements related to IND Renewable Energy Ltd (INDRENEW).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-15 01:20 IST
Prelude Therapeutics price target raised to $6 from $3 at Citizens
Finviz2026-03-11 10:03:50
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
Finviz2026-03-11 12:03:49
Curanex Appoints Two Veteran Industry Leaders to Scientific Advisory Board
Finviz2026-03-11 12:03:50
NanoViricides Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026 - Announces Manufacture of Phase II Clinical Product NV-387 Oral Gummies is Complete
Finviz2026-03-11 12:37:19
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID
Finviz2026-03-11 12:48:49
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-12 10:03:54
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Finviz2026-03-12 11:03:49
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:03:53
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing
Finviz2026-03-12 12:03:52
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
Finviz2026-03-12 12:03:53
Dare Bioscience Participates in Virtual Investor "What This Means" Segment
Finviz2026-03-12 12:03:53
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Finviz2026-03-12 13:04:04
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
Finviz2026-03-12 13:34:04
Exelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
101 finance2026-03-12 16:40:37
Hallador Energy Company Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-12 20:09:50
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Finviz2026-03-13 12:06:56
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
Finviz2026-03-13 13:19:02
Callan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal in the Treatment of Long COVID
Finviz2026-03-11 12:48:49
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
Finviz2026-03-11 20:12:54
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-12 10:03:54
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-12 11:03:48
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
Finviz2026-03-12 11:03:49
MBX Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:03:53
Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing
Finviz2026-03-12 12:03:52
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates
Finviz2026-03-12 12:03:53
Dare Bioscience Participates in Virtual Investor "What This Means" Segment
Finviz2026-03-12 12:03:53
Candel Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
Finviz2026-03-12 12:09:10
NeurAxis to Host Fourth Quarter and Full Year 2025 Results and Business Update Call on Thursday, March 19, 2026
Finviz2026-03-12 13:04:04
Curanex Expands Scientific Advisory Board With Two Distinguished Researchers
Finviz2026-03-12 13:34:04
Exelixis (EXEL) Has Fallen 2.8% Since Its Previous Earnings Report: Is a Recovery Possible?
101 finance2026-03-12 16:40:37
Hallador Energy Company Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Finviz2026-03-12 20:09:50
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Finviz2026-03-13 12:06:56
NeOnc Technologies Appoints David Choi as Chief Accounting Officer
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Finviz2026-03-13 13:03:11
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
Finviz2026-03-13 13:19:02
INDRENEW stock price change
On the last trading day, INDRENEW stock closed at 11.02 INR, with a price change of 0.73% for the day.
Trade stock perpsINDRENEW stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more